China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. It operates through the following segments: Proprietary Products Production and Sales, and Miacalcic. The Proprietary Products Production and Sales segment engages in the production and sales of the company branded products and generic drugs. The Miacalcic segment includes in the selling and marketing Miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, osteoporosis, Paget's disease, hypercalcemia and reflex sympathetic dystrophy syndrome and sub-licensing of intellectual property rights and distribution rights of Miacalcic Injection and Miacalcic Nasal Spray. The company was founded by Tit Ng and Yu Chin on March 01, 2010 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company